Novartis division Sandoz inaugurates facility in Maharashtra for oral cancer medicines
The plant, which is spread over 32,000 square metres, would cater to the export markets, it added.
New Delhi: Drug firm, Novartis India, has recently announced that the company's division Sandoz Technical Operations has inaugurated a new manufacturing facility in Maharashtra.
Sanjay Murdeshwar, Country President, Novartis India said, "This marks an important milestone for us at Novartis, and particularly for our Sandoz division, a global leader in generic pharmaceuticals and biosimilars. The inauguration of the new production and launch site for Oncology oral solids at Kalwe in India is a step forward in our constant endeavour to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Moreover, the launch of this facility will support the government's 'Make in India' vision to find solutions for the evolving needs of patients around the world."
Novartis has three legal entities -- Novartis Healthcare Pvt Ltd, Novartis India and Sandoz Pvt Ltd, employing more than 10,000 people.
